From Innovation to Inquiry — COVID-19 mRNA Vaccination and Its Global Consequences — with Special Reference to New Zealand
DOI:
https://doi.org/10.56098/hqjnk479Keywords:
adverse events, Emergency Use Authorization, EUA, genetic engineering, IgG4 class switching, mRNA gene therapies, mRNA vaccines, COVID-19 mRNA vaccines, plasmid DNAs, post-market surveillance, therapeurtic suppression, ivermectin, spike protein toxicity, regulatory oversight failure, scientific censorship, turbo cancer, vaccine induced thrombotic thrombocytopenia, VITTAbstract
The COVID-19 pandemic involved the rapid deployment of novel biomedical technologies. Chief among them were synthetic RNAs, introduced with limited longitudinal data, yet supported by institutional consensus, and expedited regulatory pathways. Subsequent developments revealed questions regarding safety, ethics, efficacy, and governance. This formal review, with specific reference to New Zealand, examines the COVID-19 response, using synthetic RNA distributed under Emergency Use Authorizations. A range of post-deployment signals, including immunological anomalies (IgG4 class switching), clotting disorders, and residual DNA elements, remain insufficiently investigated. Regulatory responses have not met the standard of precaution typically applied to novel gene therapies. At the same time, low-cost interventions such as ivermectin were de-prioritized, or suppressed. The temporal association between vaccine rollouts and excess non-COVID mortality in several high-uptake nations warrants systematic, transparent analysis. To date, no national authority has published comprehensive disaggregated mortality data by vaccination status.
References
Aalberse, R. C., Stapel, S. O., Schuurman, J., & Rispens, T. (2009). Immunoglobulin G4: An odd antibody. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, 39(4), 469–477. https://doi.org/10.1111/j.1365-2222.2009.03207.x
Abinader, L. G. (2021, March 3). Unredacted Pfizer contract with Dominican Republic, shows broad indemnity provisions for COVID-19 vaccine sales. Knowledge Ecology International. https://www.keionline.org/35485
Acevedo-Whitehouse, K., & Bruno, R. (2023). Potential health risks of mRNA-based vaccine therapy: A hypothesis. Medical Hypotheses, 171, 111015. https://doi.org/10.1016/j.mehy.2023.111015
Achiron, A., Mandel, M., Gurevich, M., Dreyer-Alster, S., Magalashvili, D., Sonis, P., Dolev, M., Menascu, S., Harari, G., Flechter, S., & Falb, R. (2022). Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod. Journal of Neurology, 269(5), 2286–2292. https://doi.org/10.1007/s00415-022-11030-0
AFP Thailand. (2024, February 28). False claims linking “white clots” to mRNA vaccines resurface online in Thailand. https://factcheck.afp.com/doc.afp.com.34KB4DG
Akdis, C. A., & Akdis, M. (2011). Mechanisms of allergen-specific immunotherapy. Journal of Allergy and Clinical Immunology, 127(1), 18–27. https://doi.org/10.1016/j.jaci.2010.11.030
Allen, A. (2022, July 5). How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence. KFF Health News. https://kffhealthnews.org/news/article/pfizer-pandemic-vaccine-market-paxlovid-outsize-profit-influence/
American Medical Association. (2021, September 1). AMA, APhA, ASHP statement on ending use of ivermectin to treat COVID-19. American Medical Association. https://www.ama-assn.org/press-center/ama-press-releases/ama-apha-ashp-statement-ending-use-ivermectin-treat-covid-19
Armour, S. (2025, March 10). MRNA Vaccines, Once a Trump Boast, Now Face Attacks From Some in GOP. KFF Health News. https://kffhealthnews.org/news/article/mrna-vaccines-trump-boast-under-gop-attacks-legislation/
Australian Bureau of Statistics. (2023, December 18). Measuring Australia’s excess mortality during the COVID-19 pandemic until August 2023. https://www.abs.gov.au/articles/measuring-australias-excess-mortality-during-covid-19-pandemic-until-august-2023
Banoun, H. (2023). mRNA: Vaccine or gene therapy? The safety regulatory issues. International Journal of Molecular Sciences, 24(13), Article 13. https://doi.org/10.3390/ijms241310514
Beattie, K. A. (2021). Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A BigData Analysis of 145 Countries. Available at this link.
Behera, P., Patro, B. K., Singh, A. K., Chandanshive, P. D., R, R. S., Pradhan, S. K., Pentapati, S. S. K., Batmanabane, G., Mohapatra, P. R., Padhy, B. M., Bal, S. K., Singh, S. R., & Mohanty, R. R. (2021). Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study. PLOS ONE, 16(2), e0247163. https://doi.org/10.1371/journal.pone.0247163
Blaylock, R. L. (2021). COVID-19 pandemic: What is the truth? Surgical Neurology International, 12, 591. https://doi.org/10.25259/SNI_1008_2021
Blaylock, R. L. (2022). COVID update: What is the truth? Surgical Neurology International, 13, 167. https://doi.org/10.25259/SNI_150_2022
BMJ. (1996). The Nuremberg Code. British Medical Journal, 313(7070), 1448. https://media.tghn.org/medialibrary/2011/04/BMJ_No_7070_Volume_313_The_Nuremberg_Code.pdf
Bor, J., Raquib, R. V., Wrigley-Field, E., Woolhandler, S., Himmelstein, D. U., & Stokes, A. C. (2025). Excess US deaths before, during, and after the COVID-19 pandemic. JAMA Health Forum, 6(5), e251118. https://doi.org/10.1001/jamahealthforum.2025.1118
Bringhurst, T. (2025, April 14). Idaho governor signs bill making ivermectin available without prescription. Ktvb.Com. https://www.ktvb.com/article/news/local/capitol-watch/idaho-governor-signs-bill-making-ivermectin-available-without-prescription-law/277-f45f6beb-c95a-4355-9feb-bfdc744f6d4a
Brown, G. W., Rhodes, N., Tacheva, B., Loewenson, R., Shahid, M., & Poitier, F. (2023). Challenges in international health financing and implications for the new pandemic fund. Globalization and Health, 19(1), 97. https://doi.org/10.1186/s12992-023-00999-6
Bryant, A., Lawrie, T. A., Dowswell, T., Fordham, E. J., Mitchell, S., Hill, S. R., & Tham, T. C. (2021). Ivermectin for prevention and treatment of COVID-19 infection: A systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines. American Journal of Therapeutics, 28(4), e434. https://doi.org/10.1097/MJT.0000000000001402
Buckhaults, P. (Director). (2023, September 14). Phillip Buckhault’s testimony on DNA contamination in Pfizer’s mRNA vaccine [Video recording]. https://rumble.com/v3kcmr4-dr.-phillip-buckhaults-testimony-on-dna-contamination-in-pfizers-mrna-vacci.html
Buckhaults, P. (2025). Phillip Buckhaults, Ph.D., Professor Department of Drug Discovery & Biomedical Sciences (DDBS) College of Pharmacy; [email protected]; Jones Physical Sciences Center 745 Main Street—PSC 620 Columbia, SC 29208. https://sc.edu/study/collegesschools/pharmacy/faculty-staff/buckhaults_phillip.php
Buhre, J. S., Pongracz, T., Künsting, I., Lixenfeld, A. S., Wang, W., Nouta, J., Lehrian, S., Schmelter, F., Lunding, H. B., Dühring, L., Kern, C., Petry, J., Martin, E. L., Föh, B., Steinhaus, M., von Kopylow, V., Sina, C., Graf, T., Rahmöller, J., … Ehlers, M. (2022). mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine. Frontiers in Immunology, 13, 1020844. https://doi.org/10.3389/fimmu.2022.1020844
Bussel, J. B., Connors, J. M., Cines, D. B., Dunbar, C. E., Michaelis, L. C., Kreuziger, L. B., Lee, A. Y. Y., & Pabinger-Fasching, I. (2022, May 9). Thrombosis with thrombocytopenia syndrome. American Society of Haematology. https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia
Calello, D. P., Kazzi, Z., & Stolbach, A. I. (2022). American College of Medical Toxicology Cautions against Off-Label Prescribing of Ivermectin for the Prevention or Treatment of COVID-19. American College of Medical Toxicology. https://www.acmt.net/wp-content/uploads/2022/06/PS_210920_Cautions-Against-Off-Label-Prescribing-of-Ivermectin-for-the-Prevention-or-Treatment-of-COVID-19.pdf?utm_source=chatgpt.com
Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research, 178, 104787. https://doi.org/10.1016/j.antiviral.2020.104787
Carbajal, E. (2025, April 9). Idaho becomes 1st state to limit vaccine mandates. Becker’s Hospital Review | Healthcare News & Analysis. https://www.beckershospitalreview.com/quality/public-health/idaho-becomes-1st-state-to-prohibit-vaccine-mandates/
Carter, B. (2022, August 25). EXCLUSIVE: Fibrous clots harvested from dead bodies of vaccinated individuals found to contain higher concentrations of electrically conductive elements – Mike Adams tells Dean Ryan. NaturalNews.Com. https://www.naturalnews.com/2022-08-25-exclusive-fibrous-clots-harvesting-electrically-conductive-elements.html
Cascio Rizzo, A., Giussani, G., & Agostoni, E. C. (2022). Ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia following COVID-19 vaccine: A case report with systematic review of the literature. Cerebrovascular Diseases (Basel, Switzerland), 1–13. https://doi.org/10.1159/000524290
CEPI (Coalition for Epidemic Preparedness Innovations). (May 29, 2024). CEPI and GAVI extend partnership to target future disease outbreaks | CEPI. https://cepi.net/cepi-and-gavi-extend-partnership-target-future-disease-outbreaks
CEPI, Gavi, Gates Foundation. (2020–2023). Governance records and funding statements. https://cepi.net, https://www.gavi.org
Chaccour, C., Casellas, A., Matteo, A. B.-D., Pineda, I., Fernandez-Montero, A., Ruiz-Castillo, P., et al. (2021). The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial. eClinicalMedicine, 32. https://doi.org/10.1016/j.eclinm.2020.100720
Chrichton, C. (2024). UK COVID-19 inquiry witness statement of UKCV family. https://covid19.public-inquiry.uk/wp-content/uploads/2025/01/21170020/INQ000474462.pdf?utm_source=chatgpt.com
Cines, D. B., & Greinacher, A. (2023). Vaccine-induced immune thrombotic thrombocytopenia. Blood, 141(14), 1659–1665. https://doi.org/10.1182/blood.2022017696
Citizen, P. (2021, October 19). Pfizer’s Power. Public Citizen. https://www.citizen.org/article/pfizers-power/
ClarkCountyToday.com. (2022, September 8). More embalmers report bizarre blood clots amid COVID vax campaign—ClarkCountyToday.com. https://www.clarkcountytoday.com/news/more-embalmers-report-bizarre-blood-clots-amid-covid-vax-campaign/
COVID-19 pandemic in Montana. (2025). In Wikipedia. https://en.wikipedia.org/w/index.php?title=COVID-19_pandemic_in_Montana&oldid=1300047158Dalgleish, A. G. (2021). Re: COVID-19: Fourth vaccine doses—who needs them and why? BMJ Rapid Response.
COVID-19 vaccination mandates in the United States. (2025). In Wikipedia. https://en.wikipedia.org/w/index.php?title=COVID-19_vaccination_mandates_in_the_United_States&oldid=1299739654
Creative Proteomics. (2025, May 16). Residual DNA Testing in Biologics Manufacturing. Creative Proteomics Blog. https://www.creative-proteomics.com/blog/residual-dna-testing-biologics-safety-methods-trends/
Dalgleish, A. (2016). Interview with Professor Angus Dalgleish. Immunotherapy, 8(11), 1271–1276. https://doi.org/10.2217/imt-2016-0120
Dalgleish, A. (2023). The Origin of the COVID-19 Virus. In C. Pasternak, Evaluating a Pandemic (pp. 1–18). World Scientific. https://doi.org/10.1142/9789811262821_0001
de Graaf, M., & Kuhs, J. (2023, October 23). High numbers of excess deaths in countries with high vaccination rates. https://www.europarl.europa.eu/doceo/document/E-9-2023-003117_EN.html
Dickson, J. D. (2022, October 14). Pfizer admits: COVID vaccine was never meant to stop transmission. Michigan Capitol Confidential. http://www.michigancapitolconfidential.com/news/pfizer-admits-covid-vaccine-was-never-meant-to-stop-transmission
DiNicolantonio, J. J., Barroso-Arranda, J., & McCarty, M. (2020). Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19. Open Heart, 7(2). https://doi.org/10.1136/openhrt-2020-001350
Doshi, P. (2021). Does the FDA think these data justify the first full approval of a covid-19 vaccine? The BMJ Opinion. https://blogs.bmj.com/bmj/2021/08/23/does-the-fda-think-these-data-justify-the-first-full-approval-of-a-covid-19-vaccine/
Dowd, E., Becker, G. de, & Kennedy, R. F., Jr. (2024). “Cause Unknown”: The Epidemic of Sudden Deaths in 2021 & 2022 & 2023. Childrens Health Defense Books. https://www.skyhorsepublishing.com/9781510776395/cause-unknown/
Editorial. (2025). The rise in early-onset colorectal cancer: Now a global issue. The Lancet Gastroenterology & Hepatology, 10(2), 95. https://doi.org/10.1016/S2468-1253(24)00441-2
Embolic and thrombotic events after COVID-19 vaccination. (2023). https://en.wikipedia.org/wiki/Embolic_and_thrombotic_events_after_COVID-19_vaccination
European Court of Auditors. (2022). Special report 19/2022: EU COVID-19 vaccine procurement. https://www.eca.europa.eu/lists/ecadocuments/sr22_19/sr_eu_covid_vaccine_procurement_en.pdf
Fattorini, E., & Loner, E. (2025). Exploring vaccination narratives: An analysis of the vaccination media discourses in Italy between 2016 and 2023. Journalism and Media, 6(2), Article 2. https://doi.org/10.3390/journalmedia6020067
Formiga, F. R., Leblanc, R., de Souza Rebouças, J., Farias, L. P., de Oliveira, R. N., & Pena, L. (2021). Ivermectin: An award-winning drug with expected antiviral activity against COVID-19. Journal of Controlled Release, 329, 758–761. https://doi.org/10.1016/j.jconrel.2020.10.009
Gabel, J., & Knox, C. (2023, February 19). New Zealand records biggest increase in registered deaths in 100 years. NZ Herald. https://www.nzherald.co.nz/nz/new-zealand-records-biggest-increase-in-registered-deaths-in-100-years/BQERSTKIANCKRNNA7IL42RD52U/
Gelderloos, A. T., Verheul, M. K., Middelhof, I., de Zeeuw-Brouwer, M.-L., van Binnendijk, R. S., Buisman, A.-M., & van Kasteren, P. B. (2024). Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults. Immunity & Ageing, 21(1), 63. https://doi.org/10.1186/s12979-024-00466-9
Gibney, M. (2025, April 29). US backlash against mRNA vaccines could hinder scientific progress. PharmaVoice. https://www.pharmavoice.com/news/mrna-vaccines-us-backlash-scientific-progress-kate-broderick-trilink-maravai/746568/
Ginsbach, K., Halabi, S., Monahan, J., & Wilder, F. R. (2024). An analysis of COVAX’s equity mandate with reference to liability and indemnity. Notre Dame Journal of International & Comparative Law. https://ndjicl.org/online/2024/an-analysis-of-covaxs-equity-mandate-with-reference-to-liability-and-indemnity-analysis
Gkioulekas, E., McCullough, P. A., & Aldous, C. (2025). Critical appraisal of multidrug therapy in the ambulatory management of patients with COVID-19 and hypoxemia Part I. Evidence supporting the strength of association. The Japanese Journal of Antibiotics, 78(1), 2–34. https://doi.org/10.11553/antibiotics.78.1_2
Greinacher, A., Thiele, T., Warkentin, T. E., Weisser, K., Kyrle, P. A., & Eichinger, S. (2021). Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. New England Journal of Medicine, 384(22), 2092–2101. https://doi.org/10.1056/NEJMoa2104840
Hanrieder, T., & Kreuder-Sonnen, C. (2014). WHO Decides on the Exception? Securitization and Emergency Governance in Global Health. Security Dialogue, 45, 331–348. https://doi.org/10.1177/0967010614535833
Hatchard, G., & Dixon, G. (2021). Relationship between COVID-19 vaccination and all cause mortality for the 60+ cohort in New Zealand: A time series analysis. https://www.researchgate.net/publication/357164662_Relationship_Between_Covid-19_Vaccination_and_All_Cause_Mortality_for_the_60_Cohort_in_New_Zealand_Time_Series_Analysis
Hazan, S., Dave, S., Gunaratne, A. W., Dolai, S., Robert L Clancy, McCullough, P. A., & Borody, T. J. (2022). Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients. Future Microbiology, 17(5), 339–350. https://doi.org/10.2217/fmb-2022-0014
Heidary, F., & Gharebaghi, R. (2020). Ivermectin: A systematic review from antiviral effects to COVID-19 complementary regimen. The Journal of Antibiotics, 73(9), 593–602. https://doi.org/10.1038/s41429-020-0336-z
Hill, A., Garratt, A., Levi, J., Falconer, J., Ellis, L., McCann, K., Pilkington, V., Qavi, A., Wang, J., & Wentzel, H. (2021). Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection. Open Forum Infectious Diseases, 8(11), ofab358. https://doi.org/10.1093/ofid/ofab358
Hood, D. (2024). Cumulative excess deaths in New Zealand in the COVID-19 era: Biases from ignoring changes in population growth rates: comment. New Zealand Economic Papers, 0(0), 1–7. https://doi.org/10.1080/00779954.2024.2379781
Howard, J. (2021, July 13). Some states move to block COVID-19 vaccine requirements in public schools. CNN. https://www.cnn.com/2021/07/13/health/covid-19-vaccine-requirements-schools-analysis-wellness
Huffman, A. (2022). The ethics of using off-label medications to treat COVID-19. Annals of Emergency Medicine, 79(6), A13. https://doi.org/10.1016/j.annemergmed.2022.04.007
Hulscher, N., Cook, M., Stricker, R., & McCullough, P. (2024). excess cardiopulmonary arrest and mortality after COVID-19 vaccination in King County. Journal of Emergency Medicine Open Access, 2, 1–11. https://doi.org/10.33140/JEMOA.02.01.12
Hulscher, N., Hodkinson, R., Makis, W., & McCullough, P. A. (2024). Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis. ESC Heart Failure, n/a(n/a). https://doi.org/10.1002/ehf2.14680
Hviid, A., & Bech Svalgaard, I. (2024). Safety of BNT162b2 mRNA COVID-19 vaccine batches: A nationwide cohort study. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.01.22.24301520
Iacobucci, G. (2022). COVID-19: Fourth vaccine doses—who needs them and why? British Medical Journal Publishing Group. https://www.bmj.com/content/376/bmj.o30
Illingworth, G., Hill, A., & Kavanagh, J. (2025, April 28). NZ Royal Commission COVID-19 Lessons Learned. https://www.covid19lessons.royalcommission.nz/
Ionophore. (2025). In Wikipedia. https://en.wikipedia.org/w/index.php?title=Ionophore&oldid=1300572279
Irrgang, P., Gerling, J., Kocher, K., Lapuente, D., Steininger, P., Habenicht, K., Wytopil, M., Beileke, S., Schäfer, S., Zhong, J., Ssebyatika, G., Krey, T., Falcone, V., Schülein, C., Peter, A. S., Nganou-Makamdop, K., Hengel, H., Held, J., Bogdan, C., … Tenbusch, M. (2022). Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science Immunology, 8(79), eade2798. https://doi.org/10.1126/sciimmunol.ade2798
Kaiser, S., Kaiser, S., Reis, J., & Marschalek, R. (2025). Quantification of objective concentrations of DNA impurities in mRNA vaccines. Vaccine, 55, 127022. https://doi.org/10.1016/j.vaccine.2025.127022
Katella, K. (2024, August 1). What to Know About Rising Rates of “Early-Onset” Cancer. Yale Medicine. https://www.yalemedicine.org/news/early-onset-cancer-in-younger-people-on-the-rise?utm_source=chatgpt.com
Kelton, J. G., Arnold, D. M., & Nazy, I. (2021). Lessons from vaccine-induced immune thrombotic thrombocytopenia. Nature Reviews Immunology, 21(12), 753–755. https://doi.org/10.1038/s41577-021-00642-8
Kerr, L., Baldi, F., Lobo, R., Assagra, W. L., Proença, F. C., Chamie, J. J., Hibberd, J. A., Kory, P., & Cadegiani, F. A. (n.d.). Regular use of ivermectin as prophylaxis for COVID-19 led up to a 92% reduction in COVID-19 mortality rate in a dose-response manner: Results of a prospective observational study of a strictly controlled population of 88,012 subjects. Cureus, 14(8), e28624. https://doi.org/10.7759/cureus.28624
KFF Health News. (2025, April 25). Idaho joins list of states making ivermectin available over the counter. KFF Health News. https://kffhealthnews.org/morning-breakout/idaho-joins-list-of-states-making-ivermectin-available-over-the-counter/
Kiszel, P., Sík, P., Miklós, J., Kajdácsi, E., Sinkovits, G., Cervenak, L., & Prohászka, Z. (2023). Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history. Scientific Reports, 13(1), 13166. https://doi.org/10.1038/s41598-023-40103-x
Klok, F. A., Pai, M., Huisman, M. V., & Makris, M. (2022). Vaccine-induced immune thrombotic thrombocytopenia. The Lancet Haematology, 9(1), e73–e80. https://doi.org/10.1016/S2352-3026(21)00306-9
Kollewe, J. (2022, February 8). Pfizer accused of pandemic profiteering as profits double. The Guardian. https://www.theguardian.com/business/2022/feb/08/pfizer-covid-vaccine-pill-profits-sales
König, B., & Kirchner, J. O. (2024). Methodological considerations regarding the quantification of DNA impurities in the COVID-19 mRNA vaccine Comirnaty®. Methods and Protocols, 7(3), 41. https://doi.org/10.3390/mps7030041
Kory, P., Meduri, G. U., Varon, J., Iglesias, J., & Marik, P. E. (2021). Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. American Journal of Therapeutics, 28(3), e299-e318. https://doi.org/10.1097/MJT.0000000000001377
Kow, C. S., Merchant, H. A., Mustafa, Z. U., & Hasan, S. S. (2021). The association between the use of ivermectin and mortality in patients with COVID-19: A meta-analysis. Pharmacological Reports, 73(5), 1473–1479. https://doi.org/10.1007/s43440-021-00245-z
Kuhbandner, C., & Reitzner, M. (2024). Differential Increases in Excess Mortality in the German Federal States During the COVID-19 Pandemic. https://doi.org/10.13140/RG.2.2.13098.18880
Kujur, M., Kiran, K. A., Nag, A. R., Kujur, A., Kumar, A., & Vidyasagar. (2022). Effect of Ivermectin prophylaxis in prevention of COVID 19: Meta-analysis and systematic review. Journal of Family Medicine and Primary Care, 11(11), 6660–6667. https://doi.org/10.4103/jfmpc.jfmpc_527_22
Kumar, D. R., Hanlin, E., Glurich, I., Mazza, J. J., & Yale, S. H. (2010). Virchow’s contribution to the understanding of thrombosis and cellular biology. Clinical Medicine & Research, 8(3–4), 168–172. https://doi.org/10.3121/cmr.2009.866
Kushner, A., West, W. P., Khan Suheb, M. Z., & Pillarisetty, L. S. (2025). Virchow Triad. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK539697/
Ladapo, J. A. (2024, January 3). Florida State Surgeon General Calls for Halt in the Use of COVID-19 mRNA Vaccines | Florida Department of Health. https://www.floridahealth.gov/newsroom/2024/01/20240103-halt-use-covid19-mrna-vaccines.pr.html?utm_source=chatgpt.com
Lasrado, N., Collier, A. Y., Miller, J., Hachmann, N. P., Liu, J., Anand, T., A. Bondzie, E., Fisher, J. L., Mazurek, C. R., Patio, R. C., Rodrigues, S. L., Rowe, M., Surve, N., Ty, D. M., Wu, C., Chicz, T. M., Tong, X., Korber, B., McNamara, R. P., & Barouch, D. H. (2024). Waning immunity and IgG4 responses following bivalent mRNA boosting. Science Advances, 10(8), eadj9945. https://doi.org/10.1126/sciadv.adj9945
Leaning, J. (1996). War crimes and medical science. BMJ, 313(7070), 1413–1415. https://doi.org/10.1136/bmj.313.7070.1413
Liester, M. B. (2022). The suppression of dissent during the COVID-19 pandemic. Social Epistemology Review and Reply Collective, 11(4), 53–76. https://wp.me/p1Bfg0-6Jw
Lindner, F., & Doidge, J. (2023). Excess mortality across countries in the Western World since the COVID-19 pandemic: 2020, 2021 and 2022. BMJ Public Health, 2(1), e000282. https://bmjpublichealth.bmj.com/content/2/1/e000282
Makris, M., Pavord, S., Lester, W., Scully, M., & Hunt, B. (2021). Vaccine‐induced immune thrombocytopenia and thrombosis (VITT). Research and Practice in Thrombosis and Haemostasis, 5(5), e12529. https://doi.org/10.1002/rth2.12529
Malhotra, A. (2022). Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine—Part 1. Journal of Metabolic Health, 5(1), Article 1. https://doi.org/10.4102/jir.v5i1.71
Manniche, V., Schmeling, M., Gilthorpe, J. D., & Hansen, P. R. (2024). Reports of batch-dependent suspected adverse events of the BNT162b2 mRNA COVID-19 vaccine: Comparison of results from denmark and sweden. Medicina, 60(8), Article 8. https://doi.org/10.3390/medicina60081343
Marcolino, M. S., Meira, K. C., Guimarães, N. S., Motta, P. P., Chagas, V. S., Kelles, S. M. B., de Sá, L. C., Valacio, R. A., & Ziegelmann, P. K. (2022). Systematic review and meta-analysis of ivermectin for treatment of COVID-19: Evidence beyond the hype. BMC Infectious Diseases, 22, 639. https://doi.org/10.1186/s12879-022-07589-8
Mathieu, E., Ritchie, H., Rodés-Guirao, L., Appel, C., Gavrilov, D., Giattino, C., Hasell, J., Macdonald, B., Dattani, S., Beltekian, D., Ortiz-Ospina, E., & Roser, M. (2020). Excess mortality during the Coronavirus pandemic (COVID-19). Our World in Data. https://ourworldindata.org/excess-mortality-covid
McCarthy, D. (2022, July 14). GP denied use of unapproved ivermectin drug to treat. NZ Herald. https://www.nzherald.co.nz/nz/murupara-gp-denied-use-of-unapproved-ivermectin-drug-to-treat-patients/ATTFILOSNGIJ7EI75TI456HFPY/
McCullough, P., Alexander, P., Armstrong, R., Arvinte, C., Bain, A., Bartlett, R., Berkowitz, R., et al. (2020). Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Reviews in Cardiovascular Medicine, 21(4), 517–530. https://doi.org/10.31083/j.rcm.2020.04.264
McCullough, P. A., & Hulscher, N. (2025). Risk stratification for future cardiac arrest after COVID-19 vaccination. World Journal of Cardiology, 17(2), 103909. https://doi.org/10.4330/wjc.v17.i2.103909
McGill, K. (2023, September 1). Court revives doctors’ lawsuit saying FDA overstepped its authority with anti-ivermectin campaign. AP News. https://apnews.com/article/coronavirus-ivermectin-fda-doctors-lawsuit-bbc8d4fc726c08940ae4b0dad70170e0
Mcilvenna, P., & O’Looney, J. (Directors). (2025, June). Funeral Director “The Time To Speak Out is Now” | John O’Looney [Video recording]. https://rumble.com/v6uqfef-funeral-director-the-time-to-speak-out-is-now-john-olooney.html
Mead, M. N., Seneff, S., Wolfinger, R., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024). COVID-19 modified mRNA “vaccines”, Part 1: Lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex. International Journal of Vaccine Theory, Practice, and Research, 3(1), 1112–1178. https://doi.org/10.56098/fdrasy50
Mead, M. N., Seneff, S., Rose, J., Wolfinger, R., McCullough, P. A., & Hulscher, N. (2024). COVID-19 modified mRNA “vaccines”: Lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex, part 2. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1275–1344. https://doi.org/10.56098/w66wjg87
Medsafe New Zealand Medicines and Medical Devices Safety Authority. (2021, September 6). Risks of importing or prescribing ivermectin for prevention or treatment of COVID-19. https://www.medsafe.govt.nz/safety/Alerts/ivermectin-covid19.htm?utm_source=chatgpt.com
Medsafe New Zealand Medicines and Medical Devices Safety Authority. (2022, August 8). Response to your request for official information. . . relating to ivermectin. https://www.health.govt.nz/system/files/2022-09/h2022007244_response.pdf
Meier, D. (2024, September 16). The future of excess mortality after COVID-19 | Swiss Re. https://www.swissre.com/institute/research/topics-and-risk-dialogues/health-and-longevity/covid-19-pandemic-synonymous-excess-mortality.html?utm_source=chatgpt.com
Michels, C., Perrier, D., Kunadhasan, J., Clark, E., Gehrett, J., Gehrett, B., Kwiatek, K., Adams, S., Chandler, R., Stagno, L., Damian, T., Delph, E., & Flowers, C. (2023). Forensic analysis of the 38 subject deaths in the 6-Month Interim Report of the Pfizer/BioNTech BNT162b2 mRNA Vaccine Clinical Trial. International Journal of Vaccine Theory, Practice, and Research, 3(1), 973–1008. https://doi.org/10.56098/ijvtpr.v3i1.85
Moderna. (2022). Moderna 2021 Annual Report. https://s29.q4cdn.com/435878511/files/doc_financials/2021/ar/Moderna-2021-Annual-Report.pdf
Mostert, S., Hoogland, M., Huibers, M., & Kaspers, G. (2024). Excess mortality across countries in the Western World since the COVID-19 pandemic: ‘Our World in Data’ estimates of January 2020 to December 2022. BMJ Public Health, 2(1), e000282. https://doi.org/10.1136/bmjph-2023-000282
Msemburi, W., Karlinsky, A., Knutson, V., Aleshin-Guendel, S., Chatterji, S., & Wakefield, J. (2023). The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature, 613(7942), 130–137. https://doi.org/10.1038/s41586-022-05522-2
Muir, K.-L., Kallam, A., Koepsell, S. A., & Gundabolu, K. (2021). Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. New England Journal of Medicine, 384(20), 1964–1965. https://doi.org/10.1056/NEJMc2105869
Murala, M. S. T., Gairola, V., Sayedahmed, E. E., & Mittal, S. K. (2025). Next-generation adenoviral vector-based vaccines for severe acute respiratory syndrome coronavirus-2. Vaccines, 13(4), Article 4. https://doi.org/10.3390/vaccines13040406
National Academies Press. (2024). Myocarditis, Pericarditis, and COVID-19 Vaccines (Chapter 7). In Evidence Review of the Adverse Effects of COVID-19 Vaccination and Intramuscular Vaccine Administration (pp. 131–212). Washington, DC: National Academies Press. https://doi.org/10.17226/27746
Nance, K. D., & Meier, J. L. (2021). Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines. ACS Central Science, 7(5), 748–756. https://doi.org/10.1021/acscentsci.1c00197
Nevradakis, M. (2025). Kentucky, Montana, Idaho among states looking to ban mRNA vaccines. Science, Public Health Policy and the Law. https://publichealthpolicyjournal.com
Nuremberg Code. (1947). Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. Vol. 2. https://www.nejm.org/doi/full/10.1056/NEJM199711133372006
Nyström, S., & Hammarström, P. (2022). Amyloidogenesis of SARS-CoV-2 spike protein. Journal of the American Chemical Society, 144(20), 8945–8950. https://doi.org/10.1021/jacs.2c03925
Office of the Commissioner US FDA. (2025). Ivermectin and COVID-19. FDA. https://www.fda.gov/consumers/consumer-updates/ivermectin-and-covid-19
Oller, J. W., & Santiago, D. (2022). All cause mortality and COVID-19 injections: Evidence from 28 weeks of Public Health England “COVID-19 vaccine surveillance reports.” International Journal of Vaccine Theory, Practice, and Research, 2(2), 301–319. https://doi.org/10.56098/ijvtpr.v2i2.42
Oller, J. W., Jr., Santiago, D., & Broudy, D. (2025). The CDC denies magnetic elements in COVID injectables while DARPA promotes mind-control research with magnetic nanoparticles migrated to the brain. International Journal of Innovative Research in Medical Science, 10(07), 255–271. https://doi.org/10.23958/ijirms/vol10-i07/2101
O’Looney, J., Hirschman, R., & Faithfull, B. (2022, October 11). Funeral Directors & Embalmers Unite to Expose A Day in the Death of Life—Counterspin Media. https://ugetube.com/watch/tJorwmSg5i6FVOd
Opsahl, R. (2025, March 4). Bill banning mRNA vaccines in Iowa passes subcommittee • Iowa Capital Dispatch. Iowa Capital Dispatch. https://iowacapitaldispatch.com/2025/03/03/bill-banning-mrna-vaccines-in-iowa-passes-subcommittee/
Oxfam. (2021, October 29). Vaccine monopolies make cost of vaccinating the world against COVID at least 5 times more expensive than it could be. Oxfam International. https://www.oxfam.org/en/press-releases/vaccine-monopolies-make-cost-vaccinating-world-against-covid-least-5-times-more
Oxford–AstraZeneca COVID-19 vaccine. (2025). In Wikipedia. https://en.wikipedia.org/w/index.php?title=Oxford%E2%80%93AstraZeneca_COVID-19_vaccine&oldid=1300845726
Paul Ehrlich Institute. (2023, December 22). Methodology for testing COVID-19 mRNA vaccines for alleged contaminants. https://www.pei.de/SharedDocs/Downloads/EN/newsroom-en/notification/231222-testing-mrna-vaccinas-dna-contamination.pdf?__blob=publicationFile&v=4
Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., Rampotas, A., Ambler, G., & Makris, M. (2021). Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. New England Journal of Medicine, 385(18), 1680–1689. https://doi.org/10.1056/NEJMoa2109908
Pekruhn, D., & Abbasi, E. (2022, January 19). Vaccine Mandates by State: Who is, Who isn’t, and How? LeadingAge. https://leadingage.org/workforce-vaccine-mandates-state-who-who-isnt-and-how/
Pelech, S., & Shaw, C. A. (2024). Down the COVID-19 Rabbit Hole. Skyhorse Publishing. https://www.amazon.com/Down-COVID-19-Rabbit-Hole-Independent/dp/1510779590
Pérez, C. M., Ruiz-Rius, S., Ramírez-Morros, A., Vidal, M., Opi, D. H., Santamaria, P., Blanco, J., Vidal-Alaball, J., Beeson, J. G., Molinos-Albert, L. M., Aguilar, R., Ruiz-Comellas, A., Moncunill, G., & Dobaño, C. (2025). Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections. Journal of Infection, 90(4). https://doi.org/10.1016/j.jinf.2025.106473
Pfannenstiel, K. (2025, April). In Idaho, ivermectin can be sold over the counter—After Gov. Little signs bill • Idaho Capital Sun. Idaho Capital Sun. https://idahocapitalsun.com/briefs/in-idaho-ivermectin-can-be-sold-over-the-counter-after-gov-little-signs-bill/
Pfizer. (2022). Pfizer’s financial performance in 2021 | Pfizer 2021 Annual Report. https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2021/performance/
Popp, M., Stegemann, M., Metzendorf, M.-I., Gould, S., Kranke, P., Meybohm, P., Skoetz, N., & Weibel, S. (2021). Ivermectin for preventing and treating COVID‐19. Cochrane Database of Systematic Reviews, 7. https://doi.org/10.1002/14651858.CD015017.pub2
Priya, N. V. (2022, February 25). Moderna reports $18.5bn total revenue in full-year 2021. Pharmaceutical Technology. https://www.pharmaceutical-technology.com/news/moderna-reports-revenue-2021/
Pushkaran, A., Chattu, V. K., & Narayanan, P. (2023). A critical analysis of COVAX alliance and corresponding global health governance and policy issues: A scoping review. BMJ Global Health, 8(10), e012168. https://doi.org/10.1136/bmjgh-2023-012168
Rancourt, D. G., & Hickey, J. (2023a). COVID-19 vaccine-associated mortality in the Southern Hemisphere. ResearchGate. https://doi.org/10.13140/RG.2.2.12702.69444
Rancourt, D. G., & Hickey, J. (2023b). Quantitative evaluation of whether the Nobel-Prize-winning COVID-19 vaccine actually saved millions of lives. Correlation Research in the Public Interest. https://correlation-canada.org/report
Rancourt, D. G., Baudin, M., Hickey, J., & Mercier, J. (2023a). COVID-19 vaccine-associated mortality in the Southern Hemisphere. CORRELATION: Research in the Public Interest. https://correlation-canada.org/covid-19-vaccine-associated-mortality-in-the-southern-hemisphere/
Rancourt, D., Baudin, M., & Mercier, J. (Directors). (2023b). Staggering 17 million deaths after COVID jab rollouts [Video recording]. https://www.bitchute.com/video/jJg7E2ajQN2J/
Reed, T. (2025, March 6). States push fight against mRNA vaccines. Axios. https://www.axios.com/2025/03/06/states-push-fight-against-mrna-vaccines
Regenstein, M., Mead, K., Trott, J., Seyoum, S., Baños, J., Bronkhorst, H. V., Benoit, M.-A., & Hughes, D. (2022). The public health response to COVID-19 in the St. Louis region of Missouri. Reports on Missouri’s Public Health Response to COVID-19. https://hsrc.himmelfarb.gwu.edu/sphhs_policy_missouri/3
Reuters. (2021, May 10). Far-right using COVID conspiracy theories to lure young -UK police | Reuters. https://www.reuters.com/world/uk/far-right-using-covid-conspiracy-theories-lure-young-uk-police-2021-05-10/
Rodriguez, E. V. C., Bouazza, F.-Z., Dauby, N., Mullier, F., d’Otreppe, S., Jissendi Tchofo, P., Bartiaux, M., Sirjacques, C., Roman, A., Hermans, C., & Cliquennois, M. (2022). Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: First documented case outside US. Infection, 50(2), 531–536. https://doi.org/10.1007/s15010-021-01712-8
Rubio-Casillas, A., Cowley, D., Uversky, V. N., Redwan, E. M., Brogna, C., & Piscopo, M. (2025). Does SARS-CoV-2 possess “allergen-like” epitopes? COVID, 5(4), 55. https://doi.org/10.3390/covid5040055
Santiago, D. (2022a). A partial answer to the question posed by David A. Hughes, PhD, in the article: “What is in the so-called COVID-19 ‘vaccines’? Part 1: evidence of a global crime against humanity.” International Journal of Vaccine Theory, Practice, and Research, 2(2), 587–594. https://doi.org/10.56098/ijvtpr.v2i2.56
Santiago, D. (2022b). Playing Russian Roulette with every COVID-19 injection: The deadly global game. International Journal of Vaccine Theory, Practice, and Research, 2(2), 619–650. https://doi.org/10.56098/ijvtpr.v2i2.36
Santiago, D. (2024). A Closer Look at N1-methylpseudouridine in the Modified mRNA Injectables. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1345–1366. https://doi.org/10.56098/5azda593
Santiago, D., & Oller, J. W. (2023). Abnormal clots and all-cause mortality during the pandemic experiment: Five doses of COVID-19 vaccine are evidently lethal to nearly all Medicare participants. International Journal of Vaccine Theory, Practice, and Research, 3(1), 847–890. https://doi.org/10.56098/ijvtpr.v3i1.73
Schirmacher, P. (2022). Autopsy-based evaluation of sudden deaths after COVID-19 vaccination. Clinical Research in Cardiology, 111(7), 1119–1126. https://link.springer.com/article/10.1007/s00392-021-01998-z
Schmidt, B. (2022, December 5). A clot too far: An embalmer dissects antivax misinformation about blood clots in Died Suddenly | Science-Based Medicine. https://sciencebasedmedicine.org/a-clot-too-far-an-embalmer-dissects-antivax-misinformation-about-blood-clots-in-died-suddenly/
Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., Wiedmann, M., Aamodt, A.-H., Skattør, T. H., Tjønnfjord, G. E., & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England Journal of Medicine, 384(22), 2124–2130. https://doi.org/10.1056/NEJMoa2104882
Semeraro, A., Vilella, S., Ruffo, G., & Stella, M. (2022). Writing about COVID-19 vaccines: Emotional profiling unravels how mainstream and alternative press framed AstraZeneca, Pfizer and vaccination campaigns. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-18472-6
Sencer, D. J. (2024, September 20). 1976 Swine Flu Vaccination Program. https://www.cdc.gov/museum/online/story-of-cdc/h1n1/index.html
Seth, M. (2021, May 12). Uttar Pradesh government says early use of Ivermectin helped to keep positivity, deaths low. The Indian Express. https://indianexpress.com/article/cities/lucknow/uttar-pradesh-government-says-ivermectin-helped-to-keep-deaths-low-7311786/
Shir-Raz, Y., Elisha, E., Martin, B., Ronel, N., & Guetzkow, J. (2022). Censorship and suppression of COVID-19 heterodoxy: Tactics and counter-tactics. Minerva, 1–27. https://doi.org/10.1007/s11024-022-09479-4
Soto-Becerra, P., Culquichicón, C., Hurtado-Roca, Y., & Araujo-Castillo, R. V. (2020). Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: Results of a target trial emulation using observational data from a nationwide healthcare system in Peru (p. 2020.10.06.20208066). medRxiv. https://doi.org/10.1101/2020.10.06.20208066
Stats NZ. (2023). Monthly provisional deaths. Retrieved from: https://www.stats.govt.nz/indicators/monthly-deaths/
Tahir, D. (2023, July 14). How a combination of COVID lawsuits and media coverage keeps misinformation churning. KFF Health News. https://kffhealthnews.org/news/article/covid-lawsuits-media-coverage-vaccine-misinformation/
Taylor, R. C. R. (2021). The global governance of pandemics. Sociology of Health & Illness, 43(6), 1540–1553. https://doi.org/10.1111/1467-9566.13293
te Velthuis, A. J. W., Worm, S. H. E. van den, Sims, A. C., Baric, R. S., Snijder, E. J., & Hemert, M. J. van. (2010). Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLOS Pathogens, 6(11), e1001176. https://doi.org/10.1371/journal.ppat.1001176
Thacker, T. (2021, September 23). ICMR removes ivermectin and hydroxycholoquine (HCQ) from COVID-19 treatment guidelines. The Economic Times. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/icmr-removes-ivermectin-and-hydroxycholoquine-hcq-from-covid-19-treatment-guidelines/articleshow/86461488.cms?from=mdr
The White House. (2025, February 15). Fact Sheet: President Donald J. Trump Prohibits Federal Funding for COVID-19 Vaccine Mandates in Schools. The White House. https://www.whitehouse.gov/fact-sheets/2025/02/fact-sheet-president-donald-j-trump-prohibits-federal-funding-for-covid-19-vaccine-mandates-in-schools/
Therapeutic Goods Administration (TGA). (2023, May 3). Removal of prescribing restrictions on ivermectin [Text]. Therapeutic Goods Administration (TGA). https://www.tga.gov.au/news/media-releases/removal-prescribing-restrictions-ivermectin
Timeline of the COVID-19 pandemic in New Zealand (2024). (2025). In Wikipedia. https://en.wikipedia.org/w/index.php?title=Timeline_of_the_COVID-19_pandemic_in_New_Zealand_(2024)&oldid=1284535353
Townshend, K. (2025, July 24). Doctor who told patients to hold Omicron parties named. https://www.nzdoctor.co.nz/article/news/doctor-who-told-patients-hold-omicron-parties-named
Trigoso, E. (2022, September 2). Embalmers Have Been Finding Numerous Long, Fibrous Clots That Lack Post-Mortem Characteristics. Www.Theepochtimes.Com. https://www.theepochtimes.com/embalmers-have-been-finding-numerous-long-fibrous-clots-that-lack-post-mortem-characteristics_4696015.html
TS News. (2021, May 12). Uttar Pradesh Health Officials on Record: Ivermectin as Prophylactic Has Lowered COVID-19 Infection Rate & Death Rates. Trialsitenews. https://www.trialsitenews.com/a/uttar-pradesh-health-officials-on-record-ivermectin-as-prophylactic-has-lowered-covid-19-infection-rate-death-rates
Turkia, M. (2021). A timeline of ivermectin-related events in the COVID-19 pandemic. https://doi.org/10.13140/RG.2.2.13705.36966
UNESCO (2005). Universal Declaration on Bioethics and Human Rights. Article 6: Consent. https://unesdoc.unesco.org/ark:/48223/pf0000146180
Uversky, V. N., Redwan, E. M., Makis, W., & Rubio-Casillas, A. (2023). IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein. Vaccines, 11(5), 991. https://doi.org/10.3390/vaccines11050991
Van Rampelbergh, R., Pavord, S., Anaya-Velarde, L., van Paassen, V., Hardt, K., Tatar, E., Ruiz-Guiñazú, J., Baumgardner, D., Oriol Mathieu, V., Praet, N., Kristyanto, H., Sadoff, J., Douoguih, M., Xu, Y., & Struyf, F. (2025). Comparison of vaccine-induced immune thrombocytopenia and thrombosis cases following two adenovirus-vectored COVID-19 vaccines. Communications Medicine, 5(1), 168. https://doi.org/10.1038/s43856-025-00891-x
Vieths, S., Waibler, Z., & Schumann, G. G. (2025). Opting for the appropriate methodology for quantification of residual DNA impurities in mRNA vaccines. Vaccine, 56, 127186. https://doi.org/10.1016/j.vaccine.2025.127186
Virchow’s triad. (2024). In Wikipedia. https://en.wikipedia.org/w/index.php?title=Virchow%27s_triad&oldid=1243174720
Wallis, V. (2023). The Impact of Censorship on COVID-19 Policy Formation in the United States. Medical Research Archives [S.I.], 11(4). https://doi.org/10.18103/mra.v11i4.3822
WHO Pandemic Treaty Draft Text (2023). https://apps.who.int/gb/inb/
WHO Pandemic Agreement. (2025). In Wikipedia. https://en.wikipedia.org/w/index.php?title=WHO_Pandemic_Agreement&oldid=1292061186
Wilson, K., & Rudge, C. (2023). COVID-19 vaccine mandates: A coercive but justified public health necessity. University of New South Wales Law Journal, 46(2). https://doi.org/10.53637/kxul1406
World Health Organization. (2022). The WHO estimates of excess mortality associated with the COVID-19 pandemic. See Msemburi et al. 2023 above.
World Trade Organization. (2022). TRIPS Waiver Negotiations and IP Access during COVID-19. https://www.wto.org/english/tratop_e/trips_e/covid19_e.htm
Xia, C., Liu, Y., & Qing, X. (2025). Trends in incidence and mortality of early-onset gastrointestinal cancers: A comprehensive study. BMC Gastroenterology, 25, 424. https://doi.org/10.1186/s12876-025-04015-6
Xue, J., Moyer, A., Peng, B., Wu, J., Hannafon, B. N., & Ding, W.-Q. (2014). Chloroquine is a zinc ionophore. PloS One, 9(10), e109180. https://doi.org/10.1371/journal.pone.0109180
Zaidi, A. K., & Dehgani-Mobaraki, P. (2022). The mechanisms of action of ivermectin against SARS-CoV-2—An extensive review. The Journal of Antibiotics, 75(2), 60–71. https://doi.org/10.1038/s41429-021-00491-6
Zalpoor, H., Nabi-Afjadi, M., Aziziyan, F., & Tavakol, C. (2023). Keeping ready against omicron and future variants: Can ivermectin prophylactic effects improve the vaccination effects against COVID-19? Archives of Pharmacology and Therapeutics, Volume 5(Issue 1), Article Issue 1. https://doi.org/10.33696/Pharmacol.4.039
Zhao, J., Xu, L., Sun, J., Song, M., Wang, L., Yuan, S., Zhu, Y., Wan, Z., Larsson, S., Tsilidis, K., Dunlop, M., Campbell, H., Rudan, I., Song, P., Theodoratou, E., Ding, K., & Li, X. (2023). Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncology, 2(1). https://doi.org/10.1136/bmjonc-2023-000049
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Bruce Rapley
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The copyright for materials in this journal, IJVTPR, is owned by the author. The author, however, grants first right of publication to the journal, IJVTPR and assures the editorial staff of the journal that the work submitted has not simultaneously been submitted to any other journal, nor is it under consideration for publication by any other journal. If any portion of the work submitted has appeared elsewhere, the quoted material is properly cited and credit is given to the original publisher. The submitting author (or the principal and corresponding author of the work) also assures the editors of IJVTPR that he or she has obtained all required written permissions from any quoted authors or publishers of quoted materials. The submitting author also agrees to hold IJVTPR and its editorial staff harmless from any infractions of copyright law that may be discovered at any time in the future in the submitted work. The author assures the editorial staff at IJVTPR that none of the work submitted is plagiarized, and that any recycled or precycled material by the author is identified as such with proper credits in the text to any other parties holding a copyright interest in the quoted material.